Sudhir K Bowry
Overview
Explore the profile of Sudhir K Bowry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hornig C, Bowry S, Kircelli F, Kendzia D, Apel C, Canaud B
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458115
Hemobiologic reactions associated with the hemoincompatibility of extracorporeal circuit material are an undesirable and inevitable consequence of all blood-contacting medical devices, typically considered only from a clinical perspective. In hemodialysis...
2.
Hornig C, Apel C, Ficociello L, Kendzia D, Anger M, Bowry S
Semin Dial
. 2022 Mar;
35(5):405-412.
PMID: 35301753
Hemodiafiltration (HDF) achieves a more efficient reduction of the uremic toxic load compared to standard high-flux hemodialysis (HF-HD) by virtue of the combined diffusive and convective clearances of a broad...
3.
Bowry S, Kircelli F, Nandakumar M, Vachharajani T
Clin Kidney J
. 2022 Jan;
14(Suppl 4):i85-i97.
PMID: 34987788
Haemodialysis (HD) utilizes the bidirectional properties of semipermeable membranes to remove uraemic toxins from blood while simultaneously replenishing electrolytes and buffers to correct metabolic acidosis. However, the nonspecific size-dependent transport...
4.
Bowry S, Kircelli F, Himmele R, Nigwekar S
Clin Kidney J
. 2022 Jan;
14(Suppl 4):i59-i71.
PMID: 34987786
Blood-incompatibility is an inevitability of all blood-contacting device applications and therapies, including haemodialysis (HD). Blood leaving the environment of blood vessels and the protection of the endothelium is confronted with...
5.
Bowry S, Kircelli F, Misra M
Clin Kidney J
. 2022 Jan;
14(Suppl 4):i32-i44.
PMID: 34987784
In haemodialysis (HD), unwanted substances (uraemic retention solutes or 'uraemic toxins') that accumulate in uraemia are removed from blood by transport across the semipermeable membrane. Like all membrane separation processes,...
6.
Bowry S, Kotanko P, Himmele R, Tao X, Anger M
Clin Kidney J
. 2022 Jan;
14(Suppl 4):i17-i31.
PMID: 34987783
Informed decision-making is paramount to the improvement of dialysis therapies and patient outcomes. A cornerstone of delivery of optimal dialysis therapy is to delineate which substances (uraemic retention solutes or...
7.
Bowry S, Chazot C
Clin Kidney J
. 2022 Jan;
14(Suppl 4):i5-i16.
PMID: 34987782
In most biological or industrial (including medical) separation processes, a membrane is a semipermeable barrier that allows or achieves selective transport between given compartments. In haemodialysis (HD), the semipermeable membrane...
8.
Bowry S, Ortiz A, Maddux F
Clin Kidney J
. 2022 Jan;
14(Suppl 4):i1-i4.
PMID: 34987781
The projected future demand for renal replacement therapies for patients with end-stage renal failure requires preparedness at different levels. The deliberations focus predominantly on the disproportionately high financial burden of...
9.
Busink E, Canaud B, Schroder-Back P, Paulus A, Evers S, Apel C, et al.
Blood Purif
. 2019 Feb;
47(1-3):156-165.
PMID: 30712033
Background: Increasing healthcare expenditures have triggered a trend from volume to value by linking patient outcome to costs. This concept first described as value-based healthcare (VBHC) by Michael Porter is...
10.
Canaud B, Busink E, Apel C, Bowry S
Blood Purif
. 2018 Apr;
46(1):7-11.
PMID: 29649802
No abstract available.